Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review

This evidence-based review addresses the question of whether testing for UGT1A1 mutations in patients with metastatic colorectal cancer treated with irinotecan leads to improvement in outcomes (e.g., irinotecan toxicity, response to treatment, morbidity, and mortality), when compared with no testing...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Palomaki, Glenn E., Bradley, Linda A., Douglas, Michael P., Kolor, Katherine, Dotson, W. David
Format: Artigo
Sprog:Inglês
Udgivet: American College of Medical Genetics 2009
Fag:
Evidence Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2743611/
https://ncbi.nlm.nih.gov/pubmed/19125129
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker